Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #7884
Reference
Drug alert 19/2023
Name
Drug alert class 4 – 19 2023 – Class 4 medicines defect information – caution in use - Drugsrus Ltd/Dawa Ltd - Metronidazole 200mg/5ml oral suspension
Categories
Scottish Government
PCA
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
MEDICINES RECALL
Description
Drugsrus Limited has informed the MHRA that a small number of bottles of Metronidazole 200 mg/5 ml Oral Suspension 100ml are leaking from the cap. The probable root cause for this defect is related to the possibility of a slight defect in the cap or bottle threads. Only the batches listed in this notification are affected. Due to the very low number of complaints received and the high visibility of the defect usually prior to dispensing, the product is not currently being recalled.
Contact Name
Irene Fazakerley
Contact Email
Contact Address
Contact Phone
Created
2023-05-23 00:00:00
Click to go back to homepage